Chronic Thromboembolic Hypertension and Pulmonary Thromboendarterectomy (CTEPH)
In-Person EventFeb 28 - Mar 01, 2014San Diego, California, USA
Speakers
OVERVIEW
This program is intended to provide a comprehensive overview of the most
r
ecent information on the risk factors and pathophysiology responsible for the
development of chronic thromboembolic pulmonary hypertension (CTEPH). And
w
ith a combination of didactic presentations and small group breakout sessions led
by experts in the field, the curriculum provides an updated approach to the
evaluation and management of patients with chronic thromboembolic disease. In
addition, topics such as post thromboendarterectomy outcomes, the appropriate
use of medical therapy in CTEPH, and the controversial role of newer anticoagulants,
IVC filters, and pulmonary angioplasty will be addressed. The course content has
been designed to provide state-of-the-art, clinically relevant topics to enhance the
clinician’
s
practice in the treatment of CTEPH patients.